Home    Back

Levothyroxine    (DrugBank: Levothyroxine)

2 diseases
IDDisease name (Link within this page)Number of trials
49Systemic lupus erythematosus1
78Hypopituitarism2

49. Systemic lupus erythematosus    [ 827 clinical trials,   638 drugs,   (DrugBank: 168 drugs),   108 drug target genes,   191 drug target pathways]
Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 827 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01276782
(ClinicalTrials.gov)		January 201112/1/2011Levothyroxine in Pregnant SLE PatientsPilot Double-Blind Placebo Controlled Trial of Levothyroxine in Pregnant Systemic Lupus Erythematosus (SLE) Patients With Autoimmune Thyroid DiseaseSystemic Lupus ErythematosusDrug: LevothyroxineJohns Hopkins UniversityNew York University School of Medicine;Duke University;University of Chicago;Stanford UniversityWithdrawn18 Years45 YearsFemale0Phase 4United States

78. Hypopituitarism    [ 462 clinical trials,   346 drugs,   (DrugBank: 45 drugs),   41 drug target genes,   80 drug target pathways]
Searched query = "Hypopituitarism", "Anterior pituitary hypothyroidism", "Syndrome of abnormal secretion of gonadotropin", "Hyposecretion of gonadotropins", "Adrenocorticotropic hormone deficiency", "ACTH deficiency", "Thyroid-stimulating hormone deficiency", "TSH deficiency", "Growth hormone deficiency", "GH deficiency", "GHD", "CGHD", "AGHD", "Prolactin deficiency", "PRL deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 462 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01574859
(ClinicalTrials.gov)		April 20127/4/2012Central Hypothyroidism and Cardiovascular RiskCentral Hypothyroidism and Cardiovascular Risk FactorsHypopituitarismOther: levothyroxineRigshospitalet, DenmarkNULLCompletedN/AN/ABoth200N/ADenmark
2EUCTR2004-005184-15-GB
(EUCTR)		24/05/200529/04/2005Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism - CHATSCentral Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism - CHATS Central (secondary/tertiary) hypothyroidism (subclinical)Trade Name: Levothyroxine
Product Name: Levothyroxine
INN or Proposed INN: Levothyroxine		Christie Hospital NHS TrustNULLNot RecruitingFemale: yes
Male: yes		80United Kingdom